The Nomination Committee’s proposal to the Annual General Meeting 2024
STOCKHOLM, February 19[th], 2024. Moberg Pharma AB (OMX: MOB) announces that the company’s Nomination Committee has decided to present the following proposal to the Annual General Meeting 2024.The Nomination CommitteeThe Nomination Committee consists of the Chairman Gillis Cullin representing Östersjöstiftelsen and the members Ida Marie Lindberg, representing Kjelsmark Holding and Kerstin Valinder Strinnholm, Chairman of the Board of Directors in the Company. Chairman of the Annual General MeetingThe Nomination Committee proposes that Kerstin Valinder Strinnholm is elected as